Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00004243 · ClinicalTrials.gov registry record · Phase 1

Docetaxel and Oxaliplatin in Treating Patients With Metastatic or Recurrent Solid Tumor

A Phase 1 study of Unspecified Adult Solid Tumor, Protocol Specific, sponsored by City of Hope Medical Center.

Completed
Registry status
Phase 1
Development phase
3
Study locations

NCT00004243 is a Phase 1 study of Unspecified Adult Solid Tumor, Protocol Specific that has completed, run by City of Hope Medical Center. The trial reports 3 study locations across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00004243, a Phase 1 study of Unspecified Adult Solid Tumor, Protocol Specific, has completed, sponsored by City of Hope Medical Center.

COMPLETED
Registry status
Phase 1
Development phase
3
Study locations

Study Summary

RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. Combining more than one drug may kill more tumor cells. PURPOSE: Phase I trial to study the effectiveness of docetaxel and oxaliplatin in treating patients who have metastatic or recurrent solid tumor.

Conditions Studied

Unspecified Adult Solid Tumor, Protocol Specific

Interventions

  • DRUG docetaxel
  • DRUG oxaliplatin

Study Locations (3)

California

  • USC/Norris Comprehensive Cancer Center - Los Angeles
  • Beckman Research Institute, City of Hope - Los Angeles
  • University of California Davis Cancer Center - Sacramento

Trial Details

FieldValue
Start Date 2000-03
Phase Phase 1

Sponsor

City of Hope Medical Center

582 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT00004243

The ClinicalTrials.gov registry entry for NCT00004243 describes a study currently listed as completed, categorized as Phase 1. An enrollment target was not published in the registry record, which is common for early-stage or observational entries. The listed sponsor is City of Hope Medical Center, which has 582 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Unspecified Adult Solid Tumor, Protocol Specific appearing as the primary indexed condition, and to 2 interventions - of which docetaxel is the first listed.

NCT00004243 reports 3 study locations spanning 1 distinct geographic area - top geographies include California.

Frequently Asked Questions

What is clinical trial NCT00004243 about?

NCT00004243 is a clinical study titled "Docetaxel and Oxaliplatin in Treating Patients With Metastatic or Recurrent Solid Tumor". RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. Combining more than one drug may kill more tumor cells. PURPOSE: Phase I trial to study the effectiveness of docetaxel and oxaliplatin in treating patients who have metastatic or ...

What is the current status of trial NCT00004243?

This trial is currently completed. It is a Phase 1 study. The study started on 2000-03.

What conditions does trial NCT00004243 study?

This clinical trial studies the following conditions: Unspecified Adult Solid Tumor, Protocol Specific.

What interventions are being tested in trial NCT00004243?

The interventions under investigation include: docetaxel (DRUG), oxaliplatin (DRUG).

Who is sponsoring clinical trial NCT00004243?

This trial is sponsored by City of Hope Medical Center, which has 582 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT00004243 being conducted?

This trial has 3 study locations across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Unspecified Adult Solid Tumor, Protocol Specific

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

Unspecified Adult Solid Tumor, Protocol Specific

All registered trials for this condition

California

All trials with a study site in California

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.